Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Metagenomi (MGX) Cash from Financing Activities (2023 - 2025)

Metagenomi (MGX) has disclosed Cash from Financing Activities for 3 consecutive years, with $74000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Cash from Financing Activities changed N/A to $74000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was -$356000.0, a 100.42% decrease, with the full-year FY2025 number at -$356000.0, down 100.42% from a year prior.
  • Cash from Financing Activities was $74000.0 for Q4 2025 at Metagenomi, up from -$187000.0 in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $86.5 million in Q1 2024 to a low of -$2.0 million in Q2 2024.
  • A 3-year average of $7.7 million and a median of -$166000.0 in 2025 define the central range for Cash from Financing Activities.
  • Biggest YoY gain for Cash from Financing Activities was 1914.83% in 2024; the steepest drop was 5110.26% in 2024.
  • Metagenomi's Cash from Financing Activities stood at -$1.3 million in 2023, then surged by 63.12% to -$492000.0 in 2024, then skyrocketed by 115.04% to $74000.0 in 2025.
  • Per Business Quant, the three most recent readings for MGX's Cash from Financing Activities are $74000.0 (Q4 2025), -$187000.0 (Q3 2025), and -$166000.0 (Q2 2025).